Jeffrey Laurence

6PUBLICATIONS
9CO-AUTHORS
Neurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 08, 2026
Aging and AIDS: A Need for Focus on Neurodegenerative Diseases and the Broad Benefits of Such Research.

|Aug 21, 2023
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation.

Mohammad Alhomoud, Cynthia Magro, Surya Seshan

|May 16, 2023
MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence.

Sonia Elhadad, David Redmond, Jenny Huang

|Jun 06, 2022
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Sonia Elhadad, Amy Chadburn, Cynthia Magro

|Jul 08, 2021
Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients.

Sandeep Subrahmanian, Alain Borczuk, Steven Salvatore

|Jul 19, 2020
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.

S Elhadad, J Chapin, D Copertino

Pageof 1

Frequent Collaborators

2 joint publications

Tsiporah Shore

1 joint publications

Jasimuddin Ahamed

1 joint publications

Amy Chadburn

1 joint publications

Koen Van Besien